These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2973592)

  • 1. [Role of ceftazidime in severe infections in children. Review of the literature].
    Bégué P; Quinet B
    Presse Med; 1988 Oct; 17(37):1944-7. PubMed ID: 2973592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Probabilistic treatment with ceftazidime of severe infections in children].
    Bégué P
    Presse Med; 1988 Oct; 17(37):1985-7. PubMed ID: 2973603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
    Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
    Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime therapy for serious infections.
    Bint AJ; Constable J; Patton KR; Constable FL
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results of the treatment of bacterial infections in children with ceftazidime].
    Zoch-Zwierz W; Rudobielska M; Wierciński R; Winiecka W; Tomaszewska B
    Pol Tyg Lek; 1989 Apr; 44(17):390-3. PubMed ID: 2696939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G; Arlet G; Bancillon A; Schaison G
    Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of ceftazidime in the treatment of 80 infectious episodes in compromised children.
    Viscoli C; Gargani G; Facco F; Mantero E; Tuo P; Giacchino R; Campelli A; Nantron M; Perlino G
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):629-34. PubMed ID: 3908333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
    Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacology of ceftazidime in childhood].
    Sereni F; Rusconi F; Caccamo M; Boccazzi A; Cambisano W; Padoan R
    G Ital Chemioter; 1984; 31(3):223-7. PubMed ID: 6399037
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ceftazidime in common infections in childhood. Experience in 262 cases].
    Fanos V; Fostini R; Panebianco R; Danieli D
    Clin Ter; 1991 Jun; 137(5):327-32. PubMed ID: 1832605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of pyocyanic bacillus superinfections in children with cystic fibrosis using a new cephalosporin: ceftazidime].
    Labbé A; Sablayrolles B; Dechamps C; Sirot J; Marty N
    Ann Pediatr (Paris); 1986 Sep; 33(7):625-8. PubMed ID: 3096185
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections.
    Huang CK; Chen YS; Lee SS; Lin WR; Tsai HC; Lin HH; Wann SR; Chen JY; Yen MY; Liu YC
    J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of ceftazidime in paediatrics.
    Assael BM; Boccazzi A; Caccamo ML; Giunta A; Marini A; Padoan R; Rusconi F; Sereni F
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():341-6. PubMed ID: 6352640
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly.
    Vozza A; Zerman AM; Bertoni L; Cattini GC; Tosto L; Greco N; Romano F; Panebianco R; Benedetti M
    J Hosp Infect; 1990 Apr; 15 Suppl A():87-9. PubMed ID: 1971652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of the use of ceftazidime in Gram-negative infections.
    Wardle JK; Snow MH; Ingham HR; Selkon JB
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():389-93. PubMed ID: 6352650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with ceftazidime in urology in Japan.
    Kawamura N
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():65-70. PubMed ID: 6352657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime in cystic fibrosis.
    Gordts B; Dab I; Butzler JP
    Lancet; 1982 Jun; 1(8285):1355. PubMed ID: 6123654
    [No Abstract]   [Full Text] [Related]  

  • 20. Open study of ceftazidime in serious infections due to multiply-resistant bacteria.
    Pechère JC; Delisle R
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():181-8. PubMed ID: 6352619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.